Advertisement

The Nation

Tailor-made antibodies may be able to stop the crippling progression of multiple sclerosis by temporarily wiping out one variety of white blood cells that seems to play a major role in the disease, researchers said. “We’re encouraged by the results, but we are extremely cautious in not wanting to overemphasize these findings,” said Dr. Howard L. Weiner, who directed the research. Initial results of the therapy were formally presented at the annual meeting in Dallas of the American Academy of Neurology.


Advertisement